New AI methods investigate clearer depression and schizophrenia subgroups from small, noisy trials, using model abstention to boost interpretability and improve patient stratification.
Joseph Geraci, PhD, MS
Advertisement
Articles by Joseph Geraci, PhD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Dementia and the Tuberculosis Vaccine: Reduced Tau Burden With Administration in Mice
2
ALKS 7290 for Adjunctive Treatment for MDD Enters Phase 2 Study
3
Why Generic Antidepressant Cycling Falls Short: Early Augmentation and TD Risk
4
Titrating ADHD Medication to an Optimal Dose
5